TGFB1 and glioblastoma: The TISIDB immune subtype analysis shows that favorable cancers like KIRC are immunologically quiet (Figure 4A(i)), while CESC, GBM, HNSC, and STAD are characterized by lymphocyte depletion and/or TGFβ dominance (Figure 4A(ii)).